Dersalazine

CAS No. 188913-58-8

Dersalazine( —— )

Catalog No. M36326 CAS No. 188913-58-8

Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 319 Get Quote
5MG 494 Get Quote
10MG 715 Get Quote
25MG 1067 Get Quote
50MG 1444 Get Quote
100MG 1908 Get Quote
500MG 3825 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dersalazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
  • Description
    Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL Receptor | Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    188913-58-8
  • Formula Weight
    600.67
  • Molecular Formula
    C35H32N6O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1C=2C(N=C1C)=CN=CC2)C3CCN(C(/C=C(\C4=CC=C(N=NC5=CC(C(O)=O)=C(O)C=C5)C=C4)/C6=CC=CC=C6)=O)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pranlukast

    Pranlukast is a cysteinyl leukotriene receptor-1 antagonist.

  • Xeligekimab

    Xeligekimab (GR 1501) is a fully human monoclonal antibody that selectively neutralizes IL-17A, has potential anti-inflammatory activity, and can be used to study plaque psoriasis.

  • Kaempferitrin

    Kaempferitrin has antidepressant-like effect related to the serotonergic system, principally 5-HT1A.